Introduction:Basic information about Panaxadiol CAS 19666-76-3, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Panaxadiol Basic information
| Product Name: | Panaxadiol |
| Synonyms: | PANAXADIOL;DAMMARANE-3BETA,12BETA-DIOL;PANAXADIOL 98.0% BY HPLC;(20R)-20,25-Epoxy-5α-dammarane-3β,12β-diol;(20R)-Panaxadiol;PALMITIC ACID METHYLESTER 99%(RG) (SEE METHYL PALMITATE);Panaxadiol ,98%;Panaxaidol |
| CAS: | 19666-76-3 |
| MF: | C30H52O3 |
| MW: | 460.73 |
| EINECS: | |
| Product Categories: | Inhibitors;standardized herbal extract;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;Steroids;Ginseng series |
| Mol File: | 19666-76-3.mol |
|
Panaxadiol Chemical Properties
| Melting point | 250℃ |
| Boiling point | 531.3±45.0 °C(Predicted) |
| density | 1.025±0.06 g/cm3(Predicted) |
| storage temp. | Refrigerator |
| solubility | Chloroform (Slightly), Ethyl Acetate (Slightly) |
| form | Solid |
| pka | 14.82±0.70(Predicted) |
| color | White to Off-White |
| InChIKey | PVLHOJXLNBFHDX-VOXQHZRYNA-N |
| SMILES | [C@@]12(C)CC[C@@]3([H])C(C)(C)[C@@H](O)CC[C@]3(C)[C@@]1([H])C[C@@H](O)[C@]1([H])[C@H](CC[C@@]21C)[C@@]1(C)CCCC(C)(C)O1 |&1:0,4,9,13,15,18,20,22,25,27,r| |
| CAS DataBase Reference | 19666-76-3 |
Safety Information
| Safety Statements | 24/25 |
| WGK Germany | WGK 3 |
| HS Code | 29329990 |
| Storage Class | 11 - Combustible Solids |
| Hazard Classifications | Acute Tox. 4 Oral |
Panaxadiol Usage And Synthesis
| Chemical Properties | White solid |
| Uses | Panaxadiol is the purified sapogenin of ginseng saponins, which exhibits anti-tumor activity. Research has shown Panaxadiol exhibited enhancing activity towards human colorectal cancer cells. |
| Definition | ChEBI: Panaxadiol is a triterpenoid saponin. |
| in vivo | Panaxadiol (oral gavage; 10 or 30 mg/kg; once every 3 days; 30 d) inhibits the growth of HCT116 cells in a xenograft model[1].
| Animal Model: | BALB/c athymic nude mice injected with HCT116 cells[1] | | Dosage: | 10 or 30 mg/kg | | Administration: | Oral gavage; 10 or 30 mg/kg; once every 3 days; 30 days | | Result: | Inhibited the protein levels of HIF-1α, p-STAT-3 (Tyr705), PD-L1 and VEGF in tumour tissues in a dose-dependent manner. |
|
Panaxadiol Preparation Products And Raw materials
| Raw materials | Ginseng extract |